» Articles » PMID: 32016427

AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls Than in Ovulatory Women

Overview
Specialty Endocrinology
Date 2020 Feb 5
PMID 32016427
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Adolescents have more small, growing follicles and larger ovaries than normal women and are prone to anovulatory cycles (ANOV). It is unknown if a higher antral follicle count (AFC) per se contributes to ANOV in early postmenarchal girls.

Objective: To determine the relationship between AMH (an AFC biomarker), other reproductive hormones, and ANOV in postmenarchal girls and to compare AMH in girls and regularly cycling adults.

Methods: A total of 23 girls (1.7 ± 0.2 years postmenarche) and 32 historic adult controls (≤34 years) underwent serial hormone measurements during 1 to 2 menstrual cycles. Girls also had pelvic ultrasounds. AMH was measured 5 times/subject using the Ansh ultrasensitive ELISA.

Results: Girls had higher AMH than women (5.2 ± 0.3 vs. 3.3 ± 0.4 ng/mL; P < 0.01) and girls with more ovulatory (OV) cycles tended to have lower AMH than those with ANOV (2 OV 4.5 ± 0.2, 1 OV 5.7 ± 1.1, 0 OV 6.8 ± 1.1 ng/mL; P = 0.1). In girls, AMH correlated with natural-log (ln) transformed LH (r = 0.5, P = 0.01), ln_androstenedione (r = 0.6, P = 0.003), ln_testosterone (r = 0.5, P = 0.02), and ovarian volume (r = 0.7, P < 0.01) but not with FSH, estradiol, P4, or body mass index. In women, AMH correlated with estradiol and P4 (both r = -0.4, P ≤ 0.03) but not with ln_LH or body mass index.

Conclusions: In postmenarchal girls, AMH is higher than in ovulatory women and is associated with LH, androgens, and a propensity for anovulatory cycles. The cause of the transient increase in AMH and AFC during late puberty and the steps underlying the transition to a mature ovary deserve further study.

Citing Articles

Anti-Müllerian hormone levels are associated with skeletal maturity in adolescent girls in the Fels Longitudinal Study.

Ford M, Choh A, Gonzalez B, Lindheim S, Stanczyk F, McGinnis L Res Sq. 2023; .

PMID: 37841846 PMC: 10571635. DOI: 10.21203/rs.3.rs-3342941/v1.


Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.

Fraser G, Obermayer-Pietsch B, Laven J, Griesinger G, Pintiaux A, Timmerman D J Clin Endocrinol Metab. 2021; 106(9):e3519-e3532.

PMID: 34000049 PMC: 8372662. DOI: 10.1210/clinem/dgab320.

References
1.
Bridges N, Cooke A, Healy M, Hindmarsh P, Brook C . Standards for ovarian volume in childhood and puberty. Fertil Steril. 1993; 60(3):456-60. View

2.
Peters H, Faber M . The normal development of the ovary in childhood. Acta Endocrinol (Copenh). 1976; 82(3):617-30. DOI: 10.1530/acta.0.0820617. View

3.
Park A, Lawson M, Chuan S, Oberfield S, Hoeger K, Witchel S . Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism. J Clin Endocrinol Metab. 2010; 95(4):1786-92. PMC: 2853993. DOI: 10.1210/jc.2009-2106. View

4.
Salmon N, Handyside A, Joyce I . Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice. Dev Biol. 2004; 266(1):201-8. DOI: 10.1016/j.ydbio.2003.10.009. View

5.
Pierre A, Peigne M, Grynberg M, Arouche N, Taieb J, Hesters L . Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum Reprod. 2013; 28(3):762-9. DOI: 10.1093/humrep/des460. View